Works matching IS 14611457 AND DT 2004 AND VI 7

Results: 71

IJNP goes fully electronic: new online manuscript submission and review system implemented.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 379, doi. 10.1017/s1461145704004833

By:

Bernard Lerer

Publication type:

Article

Association of the C(1019)G 5-HT1A functional promoter polymorphism with antidepressant response.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 501, doi. 10.1017/s1461145704004699

By:

Sylvie Lemonde;
Lisheng Du;
David Bakish;
Pavel Hrdina

Publication type:

Article

The C(1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 453, doi. 10.1017/s1461145704004687

By:

Alessandro Serretti;
Paola Artioli;
Cristina Lorenzi;
Adele Pirovano;
Viviana Tubazio;
Raffaella Zanardi

Publication type:

Article

Human 5-HT1A receptor C(−1019)G polymorphism and psychopathology.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 441, doi. 10.1017/s1461145704004663

By:

Yung-yu Huang;
Cristina Battistuzzi;
Maria A. Oquendo;
Jill Harkavy-Friedman;
Laurence Greenhill;
Gil Zalsman;
Beth Brodsky;
Victoria Arango;
David A. Brent

Publication type:

Article

A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 507, doi. 10.1017/s1461145704004651

By:

Robert M. A. Hirschfeld;
Siegfried Kasper

Publication type:

Article

Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics See Huang et al. (this issue). Human 5-HT1A receptor C(1019)G polymorphism and psychopathology; Lemonde et al. (this issue). Association of the C(1019)G 5-HT1A functional promoter polymorphism with antidepressant response; Serretti et al. (this issue). The C(1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 381, doi. 10.1017/s1461145704004845

By:

Klaus Peter Lesch;
Lise Gutknecht

Publication type:

Article

Sildenafil-induced relapse in bipolar disorder: is nitric oxide the mechanism?

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 525, doi. 10.1017/s146114570400464x

By:

Jonathan Baggott;
Ashok N. Singh

Publication type:

Article

Buspirone to improve compliance in venlafaxine-induced movement disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 523, doi. 10.1017/s1461145704004638

By:

Zoran M. Pavlovic

Publication type:

Article

Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 481, doi. 10.1017/s1461145704004626

By:

A. Carlo Altamura;
Claudio Montresor;
Daniele Salvadori;
Emanuela Mundo

Publication type:

Article

Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 489, doi. 10.1017/s1461145704004614

By:

Enrico Lattuada;
Roberto Cavallaro;
Alessandro Serretti;
Cristina Lorenzi;
Enrico Smeraldi

Publication type:

Article

Erratum.

Published in:: 2004
Publication type:: Erratum

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 387, doi. 10.1017/s1461145704004535

By:

Todd D. Gould;
Haim Einat;
Ratan Bhat

Publication type:

Article

Repetitive transcranial magnetic stimulation as an antidepressant monotherapy in a patient with major depression, leucocytopenia and rhabdomyolysis.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 527, doi. 10.1017/s1461145704004523

By:

Arian Mobascher;
Jana Boecker;
Jaroslav Malevani;
Mareke Arends;
Ansgar Klimke;
Joachim Cordes

Publication type:

Article

Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 431, doi. 10.1017/s146114570400450x

By:

Jani Penttilä;
Jaana Kajander;
Sargo Aalto;
Jussi Hirvonen;
Kjell Någren;
Tuula Ilonen;
Erkka Syvälahti

Publication type:

Article

In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 391, doi. 10.1017/s1461145704004377

By:

Nasser Haddjeri;
Céline Faure;
Guillaume Lucas;
Ouissame Mnie-Filali;
Guy Chouvet;
Bernadette Astier;
Bernard Renaud;
Pierre Blier;
Guy Debonnel

Publication type:

Article

Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 495, doi. 10.1017/s1461145704004419

By:

Chi-Un Pae;
Hye-Sook Yu;
Jung-Jin Kim;
Chang-Uk Lee;
Soo-Jung Lee;
Tae-Youn Jun;
Chul Lee

Publication type:

Article

A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 471, doi. 10.1017/s1461145704004407

By:

Martin M. Katz;
John P. Houston;
Steven Brannan;
Charles L. Bowden;
Nancy Berman;
Alan C. Swann;
Alan Frazer

Publication type:

Article

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 415, doi. 10.1017/s1461145704004390

By:

Jun-Sheng Wang;
Ying Ruan;
Robin M. Taylor;
Jennifer L. Donovan;
John S. Markowitz

Publication type:

Article

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 461, doi. 10.1017/s1461145704004389

By:

Hsien-Yuan Lane;
Cheng-Chun Lee;
Yue-Cune Chang;
Chung-Ta Lu;
Chiung-Hsien Huang;
Wen-Ho Chang

Publication type:

Article

Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 401, doi. 10.1017/s1461145704004493

By:

Miklós Palotás;
András Palotás;
László G. Puskás;
Klára Kitajka;
Magdolna Pákáski;
Zoltán Janka;
József Molnár;
Botond Penke;
János Kálmán

Publication type:

Article

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 4, p. 421, doi. 10.1017/s1461145704004353

By:

Ingo Vernaleken;
Thomas Siessmeier;
Hans-Georg Buchholz;
Sebastian Härtter;
Christoph Hiemke;
Peter Stoeter;
Frank Rösch;
Peter Bartenstein;
Gerhard Gründer

Publication type:

Article

Effect of repeated treatment with olanzapine or olanzapine plus fluoxetine on tyrosine hydroxylase in the rat locus coeruleus.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 321, doi. 10.1017/S1461145704004468

By:

Ordway, Gregory A.;
Szebeni, Katalin

Publication type:

Article

Evidence-based pharmacotherapy of Alzheimer's disease.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 351, doi. 10.1017/S1461145704004444

By:

Evans, John Grimley;
Wilcock, Gordon;
Birks, Jacqueline

Publication type:

Article

Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 243, doi. 10.1017/S1461145704004432

By:

Du, Jing;
Szabo, Steven T.;
Gray, Neil A.;
Manji, Husseini K.

Publication type:

Article

Repetitive transcranial magnetic stimulation (rTMS) in the double-blind treatment of a depressed patient suffering from bulimia nervosa: a case report.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 371, doi. 10.1017/S1461145704004420

By:

Hausmann, Armand;
Mangweth, Barbara;
Walpoth, Michaela;
Hoertnagel, Christine;
Kramer-Reinstadler, Karin;
Rupp, Claudia I.;
Hinterhuber, Hartmann

Publication type:

Article

Effects of endogenous morphine deprivation on memory retention of passive avoidance learning in mice.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 311, doi. 10.1017/S1461145704004341

By:

Guarna, Massimo;
Ghelardini, Carla;
Galeotti, Nicoletta;
Bartolini, Alessandro;
Noli, Laura;
Neri, Carla;
Stefano, George B.;
Bianchi, Enrica

Publication type:

Article

Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 299, doi. 10.1017/S1461145704004304

By:

Suenaga, Takami;
Morinobu, Shigeru;
Kawano, Ki-ichiro;
Sawada, Takuya;
Yamawaki, Shigeto

Publication type:

Article

Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 255, doi. 10.1017/S1461145704004250

By:

Daban, Claire;
Krebs, Marie-Odile;
Bourdel, Marie-Chantal;
Willard, Dominique;
Loo, Henri;
Olié, Jean-Pierre;
Poirier, Marie-France;
Amado, Isabelle

Publication type:

Article

Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 3, p. 291, doi. 10.1017/S1461145704004195

By:

Schweitzer, Isaac;
Morris, Philip;
Hopwood, Malcolm;
Maguire, Kay;
Norman, Trevor

Publication type:

Article

A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 125, doi. 10.1017/s1461145704004262

By:

Piet Oosthuizen;
Robin Emsley;
H. Jadri Turner;
Natasha Keyter

Publication type:

Article

Focus on Polypharmacy in schizophrenia: does anyone truly benefit? See Suzuki et al. p. 133142. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia..

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 109, doi. 10.1017/s1461145704004183

By:

Donald C. Goff;
Oliver Freudenreich

Publication type:

Article

Evidence-based pharmacotherapy of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 219, doi. 10.1017/s1461145704004171

By:

Robin Emsley;
Piet Oosthuizen

Publication type:

Article

Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 183, doi. 10.1017/s146114570400416x

By:

Katharina Domschke;
Christine M. Freitag;
Gregor Kuhlenbäumer;
Anja Schirmacher;
Philipp Sand;
Peter Nyhuis;
Christian Jacob;
Jürgen Fritze;
Petra Franke;
Marcella Rietschel;
Henk S. Garritsen;
Rolf Fimmers;
Markus M. Nöthen;
Klaus-Peter Lesch;
Florian Stögbauer

Publication type:

Article

Reviewers for 2003.

Published in:: International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 241, doi. 10.1017/s1461145704004158
Publication type:: Article

Focus on Antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 113, doi. 10.1017/s1461145704004146

By:

Stephen M. Stahl

Publication type:

Article

Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 193, doi. 10.1017/s1461145704004080

By:

David A. Morilak;
Alan Frazer

Publication type:

Article

Simultaneous depletion of tryptophan, tyrosine and phenylalanine as an experimental method to probe brain monoamine function in humans.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 171, doi. 10.1017/s1461145703004073

By:

Pradeep J. Nathan;
Jay-Maree Hughes;
Bernie McInerney;
Ben J. Harrison

Publication type:

Article

Association of a functional −1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 189, doi. 10.1017/s1461145703004061

By:

Claudia Rothe;
Lise Gutknecht;
Christine Freitag;
Ralf Tauber;
Rainald Mössner;
Petra Franke;
Jürgen Fritze;
Gerd Wagner;
Gregor Peikert;
Berit Wenda;
Philipp Sand;
Christian Jacob;
Marcella Rietschel;
Markus M. Nöthen;
Henk Garritsen;
Rolf Fimmers;
Jürgen Deckert

Publication type:

Article

Citalopram challenge in social anxiety disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 177, doi. 10.1017/s146114570300405x

By:

Jakov Shlik;
Eduard Maron;
Innar Tõru;
Anu Aluoja;
Veiko Vasar

Publication type:

Article

Switching elderly chronic psychotic patients to olanzapine.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 165, doi. 10.1017/s1461145703004048

By:

Yoram Barak;
Eyal Shamir;
Ilona Mirecki;
Ronit Weizman;
Dov Aizenberg

Publication type:

Article

Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 155, doi. 10.1017/s1461145703004036

By:

Lucyna Antkiewicz-Michaluk;
Jadwiga Wardas;
Jerzy Michaluk;
Irena Romańska;
Andrzej Bojarski;
Jerzy Vetulani

Publication type:

Article

A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 117, doi. 10.1017/s1461145703004024

By:

Önder Tuǧal;
Kâzım M. Yazıcı;
A. Elif Anıl Yaǧcıoǧlu;
Ahmet Göǧüş

Publication type:

Article

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 133, doi. 10.1017/s1461145703004012

By:

Takefumi Suzuki;
Hiroyuki Uchida;
Kenji F. Tanaka;
Kensuke Nomura;
Harumasa Takano;
Akira Tanabe;
Koichiro Watanabe;
Gohei Yagi;
Haruo Kashima

Publication type:

Article

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 143, doi. 10.1017/s1461145703004000

By:

Guo-Qiang Xing;
Shani Russell;
Maree J. Webster;
Robert M. Post

Publication type:

Article

Menstrual disturbances a rare side-effect of bright-light therapy.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 239, doi. 10.1017/s1461145703003997

By:

Edda Pjrek;
Dietmar Winkler;
Matthäus Willeit;
Anastasios Konstantinidis;
Nikolaus Thierry;
Siegfried Kasper

Publication type:

Article

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 1, p. 77, doi. 10.1017/S1461145703003973

By:

Biederman, Joseph;
Spencer, Thomas;
Wilens, Timothy

Publication type:

Article

How to treat bipolar II depression and bipolar II mixed depression?

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 1, p. 105, doi. 10.1017/S146114570300395X

By:

Benazzi, Franco

Publication type:

Article

Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 1, p. 19, doi. 10.1017/S1461145703003912

By:

Takano, Akihiro;
Suhara, Tetsuya;
Ikoma, Yoko;
Yasuno, Fumihiko;
Maeda, Jun;
Ichimiya, Tetsuya;
Sudo, Yasuhiko;
Inoue, Makoto;
Okubo, Yoshiro

Publication type:

Article

Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 1, p. 65, doi. 10.1017/S1461145703003894

By:

Kemp, Andrew H.;
Nathan, Pradeep J.

Publication type:

Article

Neuroleptic malignant syndrome induced by donepezil.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 1, p. 101, doi. 10.1017/S1461145703003857

By:

Matsumoto, T.;
Kawanishi, C.;
Isojima, D.;
Iseki, E.;
Kishida, I.;
Kosaka, K.

Publication type:

Article